New study aims to cut diagnostic delays for lung scarring patients
NCT ID NCT07482917
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests whether bundling key tests like scans and lung function tests into a single, fast-tracked appointment can help people with suspected interstitial lung disease get a diagnosis sooner. About 92 adults will be randomly assigned to either the usual step-by-step testing or the streamlined approach. The goal is to see if the coordinated circuit reduces wait times, stress, and costs without compromising care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROTIC INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital General de Granollers
RECRUITINGGranollers, Barcelona, 08402, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill slow lung scarring in IPF?
- Which finger or earlobe? a study tests the best spot for oxygen monitoring in lung disease
- Can an inhaled powder stop lung scarring? a safety trial begins
- Can a new drug slow lung scarring in IPF?
- Repairing lungs from within: stem cells harvested from Patients' own airways tested for scarring disease
- Blood tests could unlock early clues for three major lung diseases